This is a Validated Antibody Database (VAD) review about mouse B7 1, based on 197 published articles (read how Labome selects the articles), using B7 1 antibody in all methods. It is aimed to help Labome visitors find the most suited B7 1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
B7 1 synonym: B71; Cd28l; Ly-53; Ly53; MIC17; TSA1

BioLegend
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend B7 1 antibody (BioLegend, 104722) was used in flow cytometry on mouse samples (fig 3a). Sci Adv (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2j
BioLegend B7 1 antibody (Biolegend, 104718) was used in flow cytometry on mouse samples (fig 2j). Cell Rep (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1a, s2b, s2c
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1a, s2b, s2c). Nat Commun (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:300; loading ...; fig 2f, s2l
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples at 1:300 (fig 2f, s2l). PLoS Pathog (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b, s7c
BioLegend B7 1 antibody (BioLegend, 104707) was used in flow cytometry on mouse samples at 1:200 (fig 4b, s7c). J Immunother Cancer (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig 1s1a, 5s1
BioLegend B7 1 antibody (BioLegend, 104722) was used in flow cytometry on mouse samples at 1:200 (fig 1s1a, 5s1). elife (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...; fig 2c, 5e, e4j
BioLegend B7 1 antibody (Biolegend, 104707) was used in flow cytometry on mouse samples at 1:100 (fig 2c, 5e, e4j). EMBO Mol Med (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples at 1:100. J Immunother Cancer (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend B7 1 antibody (Biolegend, 104707) was used in flow cytometry on mouse samples (fig 3a). Front Pharmacol (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...
BioLegend B7 1 antibody (Biolegend, 16-10AI) was used in flow cytometry on mouse samples . Int J Mol Sci (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend B7 1 antibody (Biolegend, 104707) was used in flow cytometry on mouse samples (fig 3b). Vaccines (Basel) (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...
BioLegend B7 1 antibody (Biolegend, 104706) was used in flow cytometry on mouse samples at 1:200. Aging Cell (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4i
BioLegend B7 1 antibody (Biolegend, 104702) was used in flow cytometry on mouse samples (fig 4i). Cancer Cell (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; fig s6g
BioLegend B7 1 antibody (Biolegend, 104737) was used in flow cytometry on mouse samples at 1:100 (fig s6g). Cell Rep (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 6c
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 6c). Front Immunol (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5e
BioLegend B7 1 antibody (Biolegend, 104725) was used in flow cytometry on mouse samples (fig 5e). Mol Cancer (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...
BioLegend B7 1 antibody (BioLegend, 104738) was used in flow cytometry on mouse samples . Mucosal Immunol (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5a
BioLegend B7 1 antibody (BioLegend, 104725) was used in flow cytometry on mouse samples (fig 5a). Cell Mol Gastroenterol Hepatol (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5h
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 5h). Front Immunol (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...; fig 5b
BioLegend B7 1 antibody (BioLegend, 104705) was used in flow cytometry on mouse samples at 1:100 (fig 5b). Sci Transl Med (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend B7 1 antibody (BioLegend, 1047220) was used in flow cytometry on mouse samples (fig 4a). PLoS ONE (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s9d
BioLegend B7 1 antibody (BioLegend, 104712) was used in flow cytometry on mouse samples (fig s9d). Sci Adv (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...
BioLegend B7 1 antibody (BioLegend, 104723) was used in flow cytometry on mouse samples . Nat Commun (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2c
BioLegend B7 1 antibody (Biolegend, 104706) was used in flow cytometry on mouse samples (fig 2c). Nat Commun (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5e
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 5e). Antioxidants (Basel) (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples . Mucosal Immunol (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 6b
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 6b). Acta Neuropathol (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:800; loading ...; fig 2e
BioLegend B7 1 antibody (BioLegend, 104729) was used in flow cytometry on mouse samples at 1:800 (fig 2e). elife (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 2b). Nat Commun (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2g
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 2g). Sci Adv (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1f, s2b
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1f, s2b). BMC Immunol (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...; fig 5
BioLegend B7 1 antibody (BioLegend, 104734) was used in flow cytometry on mouse samples at 1:100 (fig 5). Nat Commun (2020) ncbi
hamsters monoclonal (16-10A1)
  • mass cytometry; mouse; loading ...; fig 5d
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in mass cytometry on mouse samples (fig 5d). J Virol (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig 4b
BioLegend B7 1 antibody (BioLegend, 104714) was used in flow cytometry on mouse samples at 1:200 (fig 4b). Nat Commun (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...; fig s6c
BioLegend B7 1 antibody (Biolegend, 104729) was used in flow cytometry on mouse samples at 1:100 (fig s6c). Nat Commun (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2a, 2d
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 2a, 2d). elife (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s7d
BioLegend B7 1 antibody (BioLegend, 104725) was used in flow cytometry on mouse samples (fig s7d). Bone Res (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3d
BioLegend B7 1 antibody (BioLegend, 104714) was used in flow cytometry on mouse samples (fig 3d). J Exp Med (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s6c
BioLegend B7 1 antibody (BioLegend, 104723) was used in flow cytometry on mouse samples (fig s6c). Cell (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend B7 1 antibody (Biolegend, 104708) was used in flow cytometry on mouse samples (fig 1a). Front Immunol (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2h
BioLegend B7 1 antibody (Biolegend, 104705) was used in flow cytometry on mouse samples (fig 2h). Oncoimmunology (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:300; loading ...; fig 1a
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples at 1:300 (fig 1a). elife (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig ex4a
BioLegend B7 1 antibody (BioLegend, 104734) was used in flow cytometry on mouse samples at 1:200 (fig ex4a). Nature (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4b
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 4b). J Clin Invest (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3b
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 3b). Sci Rep (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4e
BioLegend B7 1 antibody (Biolegend, 104705) was used in flow cytometry on mouse samples (fig 4e). Cell (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1a). Science (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s4g
BioLegend B7 1 antibody (Biolegend, 104707) was used in flow cytometry on mouse samples (fig s4g). Sci Rep (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s1c
BioLegend B7 1 antibody (BioLegend, 16-0A1) was used in flow cytometry on mouse samples (fig s1c). J Immunol (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2e
BioLegend B7 1 antibody (Biolegend, 104708) was used in flow cytometry on mouse samples (fig 2e). Cell Rep (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s5
BioLegend B7 1 antibody (Biolegend, 104732) was used in flow cytometry on mouse samples (fig s5). Nat Commun (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1n
BioLegend B7 1 antibody (BioLegend, 104734) was used in flow cytometry on mouse samples (fig 1n). Cell Mol Gastroenterol Hepatol (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3a
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 3a). Front Immunol (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4a
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 4a). Front Immunol (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...; fig s1
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples at 1:100 (fig s1). Nat Commun (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s6d
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig s6d). JCI Insight (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5b
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend B7 1 antibody (Biolegend, 104706) was used in flow cytometry on mouse samples (fig 5b). Cell Death Dis (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...
In order to evaluate mouse models of hepacivirus infection, BioLegend B7 1 antibody (Biolegend, 16-10AI) was used in flow cytometry on mouse samples . Science (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5c
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 5c). Cancer Res (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1b
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1b). J Leukoc Biol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). J Exp Med (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3a
In order to explore how the different Fcgamma receptors expressed on dendritic cells affect the initiation of T cell responses, BioLegend B7 1 antibody (biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 3a). J Exp Med (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2b
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 2b). Immunology (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 6c
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 6c). J Immunol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s4b
In order to use a CRISPR-Cas9 system to screen for genes involved in B-cell activation and plasma cell differentiation, BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s4b). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s4e
In order to study T cell migration in inflammatory demyelinating lesions confined to optic nerves and spinal cord, BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s4e). Proc Natl Acad Sci U S A (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4b
In order to probe how neutrophil extracellular traps modulate the rheumatoid arthritis-associated autoimmune response, BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 4b). Eur J Immunol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; loading ...; fig 9b
In order to investigate the contribution of neutrophils and macrophages during Rickettsia typhi infection, BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples at 1:100 (fig 9b). PLoS Negl Trop Dis (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:400; loading ...; fig 1a
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples at 1:400 (fig 1a). PLoS ONE (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1a
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1a). PLoS ONE (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; human; loading ...; tbl 2
In order to assess the protective immunological events induced by vaccination with Leishmune in dogs, BioLegend B7 1 antibody (Biolegend, 104718) was used in flow cytometry on human samples (tbl 2). Vet Parasitol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3e
In order to compare the capacity of induced T regulatory and T helper 17 cells to develop in a T cell model of colitis, BioLegend B7 1 antibody (BioLegend, 16- 10A1) was used in flow cytometry on mouse samples (fig 3e). J Immunol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
In order to study dendritic cells in Sirt6 knock out mice, BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 4). Aging (Albany NY) (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...
In order to elucidate the role of miR-34a in efferocytosis, BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1
In order to determine the promotion of the formation of conjugates between transformed T helper cells and B lymphoma cells by murid gammaherpesvirus latency-associated protein M2, BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1). PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 2j
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 2j). Sci Rep (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 8
In order to study engineered anti-melanoma vaccines that modulate cytokine priming and silence PD-L1 simultaneously by use of ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy, BioLegend B7 1 antibody (BioLegend, 104713) was used in flow cytometry on mouse samples (fig 8). Oncoimmunology (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1). J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1
BioLegend B7 1 antibody (Biolegend, 16-10A1) was used in flow cytometry on mouse samples (fig 1). Biochem Biophys Res Commun (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig 3). PLoS Pathog (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100
In order to assess the role of CDH17 in the long-term survival of memory B cells in the bone marrow, BioLegend B7 1 antibody (BioLegend, 104717) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
BioLegend B7 1 antibody (BioLegend, 104714) was used . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2b
BioLegend B7 1 antibody (BioLegend, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). J Leukoc Biol (2014) ncbi
Invitrogen
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig s10c
Invitrogen B7 1 antibody (Thermo Fisher, 16-10A1) was used in flow cytometry on mouse samples at 1:200 (fig s10c). Sci Rep (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:50; loading ...; fig 8a
Invitrogen B7 1 antibody (eBioscience, 17-0801-82) was used in flow cytometry on mouse samples at 1:50 (fig 8a). Cell Death Dis (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4a, 7a
Invitrogen B7 1 antibody (Thermo Fisher, 16-10A1) was used in flow cytometry on mouse samples (fig 4a, 7a). Immunol Cell Biol (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:300; loading ...; fig 3m
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples at 1:300 (fig 3m). elife (2020) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1b
Invitrogen B7 1 antibody (eBioscience, 16-10A-1) was used in flow cytometry on mouse samples (fig 1b). Front Immunol (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 6c
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 6c). Immune Netw (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3h
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 3h). Glia (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig s2). Proc Natl Acad Sci U S A (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig e5c
Invitrogen B7 1 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig e5c). Nature (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5d
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5d). J Leukoc Biol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5a
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5a). J Exp Med (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:400; loading ...; fig s5
In order to report a CD40-dependent mechanism capable of abrogating inducible T regulatory cell induction by dendritic cells, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples at 1:400 (fig s5). Nat Commun (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3a
In order to study the D. farinae allergen Pplase in a mouse model., Invitrogen B7 1 antibody (Ebioscience, 12-0801) was used in flow cytometry on mouse samples (fig 3a). Sci Rep (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3a
In order to test the effect of paeoniflorin in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis, Invitrogen B7 1 antibody (eBioscience, 11-0801) was used in flow cytometry on mouse samples (fig 3a). Sci Rep (2017) ncbi
hamsters monoclonal (16-10A1)
  • blocking or activating experiments; mouse; loading ...; fig 7
In order to explore if the binding strength of a peptide for a MHC is a critical factor to determine the duration of pMHC-mediated T cell activation, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in blocking or activating experiments on mouse samples (fig 7). Mol Cells (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5n
In order to evaluate miR-29a in B cells as a potential therapeutic target in arthritis, Invitrogen B7 1 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 5n). Cell Mol Life Sci (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2b
In order to study the ability of lymphocyte-derived microparticles to modulate the gene expression pattern of angiogenesis-related factors in macrophages, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 2b). Sci Rep (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4B
In order to study the contribution of CXCR6/CXCL16 interactions in glycolipid-dependent invariant natural killer cell activation and tumor control, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 4B). Oncoimmunology (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s2b
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). Immunity (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig s2b
In order to elucidate the mechanistic relationships among TLRs, CD80, and albuminuria, Invitrogen B7 1 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples at 1:200 (fig s2b). Dis Model Mech (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s8
Invitrogen B7 1 antibody (eBioscience, 12-0801-85) was used in flow cytometry on mouse samples (fig s8). Sci Rep (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; fig 2
In order to determine the affects of dendritic cell migration in vitro by loss of gadkin, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples at 1:100 (fig 2). PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 5a
In order to parse the relative importance of the direct and indirect antigen presentation pathways in ectromelia virus mouse pox infection., Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5a). PLoS Pathog (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; tbl s1
In order to study the role of ICOS in group 2 innate lymphoid cell responses, Invitrogen B7 1 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (tbl s1). Biochem Biophys Res Commun (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . Nature (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s3
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig s3). PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 3). Carbohydr Polym (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2b
In order to test if blocking several checkpoint receptors boosts anti-tumor immunity in a low-dose, lymphodepleting whole body radiation model, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig s2b). J Immunother Cancer (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . Mucosal Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 2
Invitrogen B7 1 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 2). Eur J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5a
In order to test the efficacy of combining different monoclonal antibodies to treat cancer, Invitrogen B7 1 antibody (ebioscience, 14-0801-82) was used in flow cytometry on mouse samples (fig 5a). Clin Cancer Res (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
In order to investigate the use of mannosylated synthetic long peptides for vaccination, Invitrogen B7 1 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100; fig 2
Invitrogen B7 1 antibody (eBioscience, 11-0801-86) was used in flow cytometry on mouse samples at 1:100 (fig 2). PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen B7 1 antibody (eBioscience Inc., 16-10A1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; human
Invitrogen B7 1 antibody (eBioscience, 17-0801-82) was used in flow cytometry on human samples . J Immunol (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3
In order to elucidate the role of dendritic cells in cancer immunosurveillance failure, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 3). Immunol Cell Biol (2013) ncbi
rat monoclonal (RMMP-1)
  • flow cytometry; mouse; fig 1d
In order to compare two dendritic cell modification strategies to inhibit allogeneic T-cell proliferation, Invitrogen B7 1 antibody (Caltag, RMMP-1) was used in flow cytometry on mouse samples (fig 1d). Eur J Immunol (2013) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . J Exp Med (2011) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5
In order to investigate the different immune responses when mice are infected with type I or type II strains of T. gondii, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5). J Immunol (2010) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5
In order to test if upregulation of major histocompatibility complex class II and costimulatory molecules in the retina contributes to the regulation of CD4 T cells, Invitrogen B7 1 antibody (eBiosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 5). Infect Immun (2010) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 4). J Immunol (2009) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to investigate crosstalk between that osteoclasts and T cells, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2009) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to examine the origin and development of Aire positive medullary thymic epithelial cells, Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples . Nat Immunol (2007) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 5
  • flow cytometry; human
Invitrogen B7 1 antibody (eBioscience, 16-10A1) was used in flow cytometry on mouse samples (fig 5) and in flow cytometry on human samples . J Immunol (2005) ncbi
rat monoclonal (RMMP-1)
  • flow cytometry; mouse; fig 1
In order to investigate how products released by schistosome larvae affect dendritic cells, Invitrogen B7 1 antibody (Caltag, RMMP-1) was used in flow cytometry on mouse samples (fig 1). Infect Immun (2005) ncbi
rat monoclonal (RMMP-1)
  • flow cytometry; mouse; 1:50; fig 1
In order to study the interaction of human papillomavirus 16 L1/E7 chimeric virus-like particles with mouse bone marrow-derived dendritic cells activated with different immune adjuvants, Invitrogen B7 1 antibody (Caltag, RMMP-1) was used in flow cytometry on mouse samples at 1:50 (fig 1). Antivir Ther (2004) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to investigate the use of three-domain single-chain T-cell receptors, Invitrogen B7 1 antibody (Caltag, 16-10A1) was used in flow cytometry on mouse samples . Cancer Gene Ther (2004) ncbi
rat monoclonal (RMMP-1)
  • flow cytometry; mouse
In order to assess the contribution of DC function in non-obese diabetic mice, Invitrogen B7 1 antibody (Caltag, RMMP-1) was used in flow cytometry on mouse samples . Clin Exp Immunol (2003) ncbi
rat monoclonal (RMMP-1)
  • flow cytometry; mouse; fig 2
In order to investigate homeostatic B cell proliferation, Invitrogen B7 1 antibody (Caltag, RMMP-1) was used in flow cytometry on mouse samples (fig 2). J Immunol (2002) ncbi
rat monoclonal (RMMP-1)
  • flow cytometry; mouse; 0.5 ug/ml
In order to study expression of a C-type lectin specific for galactose and N-acetylgalactosamine on murine dendritic cells, Invitrogen B7 1 antibody (Caltag, RMMP1) was used in flow cytometry on mouse samples at 0.5 ug/ml. Glycobiology (2002) ncbi
rat monoclonal (RMMP-1)
  • flow cytometry; mouse; fig 5
In order to report that histone deacetylase inhibitors alter the acetylation of histones and enhance the expression of several genes on tumor cells, Invitrogen B7 1 antibody (Caltag, RMMP-1) was used in flow cytometry on mouse samples (fig 5). J Immunol (2000) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to generate and characterize mice deficient for CD37, Invitrogen B7 1 antibody (Biosource, 16-10A1) was used in flow cytometry on mouse samples . Mol Cell Biol (2000) ncbi
Miltenyi Biotec
human monoclonal (REA983)
  • flow cytometry; mouse; 1:50; loading ...; fig s13b, s14b
Miltenyi Biotec B7 1 antibody (Miltenyi Biotec, 130-116-463) was used in flow cytometry on mouse samples at 1:50 (fig s13b, s14b). Nat Commun (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s4c
Miltenyi Biotec B7 1 antibody (Miltenyi, 130-102-584) was used in flow cytometry on mouse samples (fig s4c). J Immunother Cancer (2021) ncbi
Bio X Cell
rat monoclonal (1G10)
  • blocking or activating experiments; mouse; fig 6e
Bio X Cell B7 1 antibody (BioXCell, 1G10) was used in blocking or activating experiments on mouse samples (fig 6e). Nat Commun (2022) ncbi
hamsters monoclonal (16-10A1)
  • blocking or activating experiments; mouse; fig 2e
Bio X Cell B7 1 antibody (BioXcell, 16-10A1) was used in blocking or activating experiments on mouse samples (fig 2e). elife (2020) ncbi
rat monoclonal (1G10)
  • flow cytometry; mouse; loading ...; fig 4b
Bio X Cell B7 1 antibody (Bio X Cell, 1G10) was used in flow cytometry on mouse samples (fig 4b). Biomaterials (2016) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; loading ...; fig 4f
  • immunohistochemistry - frozen section; human; loading ...; fig 4h
Abcam B7 1 antibody (Abcam, ab64116) was used in immunohistochemistry - frozen section on mouse samples (fig 4f) and in immunohistochemistry - frozen section on human samples (fig 4h). Cell (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 3
In order to analyze regulation of NLRP3 inflammasome in adipose tissue by phosphodiesterase 3B (PDE3B), Abcam B7 1 antibody (Abcam, ab-64116) was used in western blot on mouse samples (fig 3). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 2
Abcam B7 1 antibody (abcam, ab64116) was used in western blot on human samples at 1:1000 (fig 2). Nat Commun (2016) ncbi
Tonbo Biosciences
monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2a
Tonbo Biosciences B7 1 antibody (Tonbo Biosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 2a). PLoS ONE (2018) ncbi
BD Biosciences
hamsters monoclonal (16-10A1)
  • immunocytochemistry; mouse; loading ...; fig 5e
BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in immunocytochemistry on mouse samples (fig 5e). Nat Commun (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig s13c
BD Biosciences B7 1 antibody (BD Biosciences, 553769) was used in flow cytometry on mouse samples at 1:200 (fig s13c). J Clin Invest (2022) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD Biosciences, 16-10 A1) was used in flow cytometry on mouse samples . J Immunother Cancer (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s7c
BD Biosciences B7 1 antibody (BD pharmingen, 561954) was used in flow cytometry on mouse samples (fig s7c). Nat Commun (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s1d
BD Biosciences B7 1 antibody (BD, 553767) was used in flow cytometry on mouse samples (fig s1d). Nat Commun (2021) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 6a
BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples (fig 6a). Front Immunol (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 4:100; loading ...; fig 2a
BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in flow cytometry on mouse samples at 4:100 (fig 2a). Biosci Rep (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig 5d
BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples at 1:200 (fig 5d). J Pathol (2019) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4
BD Biosciences B7 1 antibody (BD Pharminger, 16-10A1) was used in flow cytometry on mouse samples (fig 4). J Diabetes Res (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s3
BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples (fig s3). Eur J Immunol (2018) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 6a
In order to study the therapeutic TnP peptide in inflammation and demyelination in a mouse model of multiple sclerosis., BD Biosciences B7 1 antibody (BD Biosciences, 553769) was used in flow cytometry on mouse samples (fig 6a). PLoS ONE (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 3C
In order to analyze the effects of a loss of autophagy in dendritic cells and B cells in a TLR7-mediated model of autoimmunity, BD Biosciences B7 1 antibody (BD Biosciences, 553769) was used in flow cytometry on mouse samples (fig 3C). J Immunol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig s2
In order to explore the ability of FhHDM-1 to modulate macrophage function, BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples (fig s2). Sci Rep (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 1c
In order to compare gene expression profiles of the embryonic stem cell- and adult progenitor-derived dendritic cells, BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig s1
In order to characterize malaria-induced splenic monocyte-derived dendritic cells, BD Biosciences B7 1 antibody (BD Bioscience, 16-10A1) was used in flow cytometry on mouse samples at 1:200 (fig s1). Nat Commun (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:500; fig S5d
BD Biosciences B7 1 antibody (BD, 553769) was used in flow cytometry on mouse samples at 1:500 (fig S5d). Nat Commun (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s6
BD Biosciences B7 1 antibody (BD Biosciences, 553769) was used in flow cytometry on mouse samples (fig s6). Nat Commun (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1d
BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 1d). J Immunol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 2
In order to study prevention of allergic skin disease by epidermal RAF, BD Biosciences B7 1 antibody (BD Bioscience, 553768) was used in flow cytometry on mouse samples (fig 2). elife (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 2b
BD Biosciences B7 1 antibody (BD Biosciences, 16-10A) was used in flow cytometry on mouse samples (fig 2b). J Immunol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:200; loading ...; fig 5e
In order to find that coagulation factor XII modulates immune responses, BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in flow cytometry on mouse samples at 1:200 (fig 5e). Nat Commun (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 4
BD Biosciences B7 1 antibody (Becton Dickinson, 16-10A1) was used in flow cytometry on mouse samples (fig 4). Vaccines (Basel) (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3
BD Biosciences B7 1 antibody (BD Pharmingen, 16-10A1) was used in flow cytometry on mouse samples (fig 3). Cell Mol Immunol (2017) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; loading ...; fig 7c
BD Biosciences B7 1 antibody (Beckon Dickinson, 553768) was used in flow cytometry on mouse samples (fig 7c). Biol Open (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100
BD Biosciences B7 1 antibody (BD Biosciences, 553768) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2016) ncbi
hamsters monoclonal (16-10A1)
  • immunocytochemistry; mouse; 1:100; fig 6
BD Biosciences B7 1 antibody (BD Biosciences, 560526) was used in immunocytochemistry on mouse samples at 1:100 (fig 6). J Immunol Res (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to assess whether flagellin is useful as an adjuvant for a topical therapeutic vaccine for female genital cancer, BD Biosciences B7 1 antibody (BD Bioscience, 16-10A1) was used in flow cytometry on mouse samples . Oncoimmunology (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:400; loading ...; fig 3a
In order to test if the combination of dendritic cells and doxorubicin results in tumor growth inhibition in a murine osteosarcoma model, BD Biosciences B7 1 antibody (BD Pharmingen, 553769) was used in flow cytometry on mouse samples at 1:400 (fig 3a). Oncol Lett (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 3c
In order to propose that neuronal autoimmunity is a pathogenic feature of type 1 diabetes, BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in flow cytometry on mouse samples (fig 3c). Diabetes (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples (fig 4). Int J Oncol (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
In order to research the connection between oligodendrocyte death and immune-mediated CNS demyelination, BD Biosciences B7 1 antibody (BD Bioscience, 560016) was used in flow cytometry on mouse samples (fig 4). Nat Neurosci (2016) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 1
In order to investigate how Tregs are maintained in adipose tissue, BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples (fig 1). Sci Rep (2015) ncbi
hamsters monoclonal (16-10A1)
  • immunocytochemistry; mouse
In order to report that carbon monoxide produced by heme-oxygenase 1 impairs DC immunogenicity using a mitochondria-dependent mechanism, BD Biosciences B7 1 antibody (BD Pharmingen, 16-10A1) was used in immunocytochemistry on mouse samples . Eur J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 2
In order to study B cells migration in vivo, BD Biosciences B7 1 antibody (BD Biosciences, 553768) was used in flow cytometry on mouse samples (fig 2). Oncoimmunology (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 2
In order to investigate the role of FAT10 in thymic antigen presentation, BD Biosciences B7 1 antibody (BD Biosciences., 16-10A1) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; human
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD Pharmingen, 16-10A1) was used in flow cytometry on human samples and in flow cytometry on mouse samples . Cancer Immunol Res (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 2
BD Biosciences B7 1 antibody (BD Pharmingen, 553769) was used in flow cytometry on mouse samples (fig 2). Mol Med Rep (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 4
BD Biosciences B7 1 antibody (BD Pharmingen, 16-10A1) was used in flow cytometry on mouse samples (fig 4). PLoS ONE (2015) ncbi
hamsters monoclonal (16-10A1)
  • immunocytochemistry; mouse
BD Biosciences B7 1 antibody (BD Pharmingen, 16-10A1) was used in immunocytochemistry on mouse samples . J Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig s3
BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples (fig s3). Brain (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; fig 6
BD Biosciences B7 1 antibody (BD Pharmingen, 16-10A1) was used in flow cytometry on mouse samples (fig 6). Clin Exp Immunol (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD Bioscience, 16-10A1) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples . Cancer Res (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
In order to investigate the role of T reg cells in exhaustion of lymphocytic choriomeningitis virus-specific CD8 T cells, BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples . J Exp Med (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD Biosciences, 16- 10A1) was used in flow cytometry on mouse samples . Blood (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in flow cytometry on mouse samples . Int J Cancer (2015) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD, 16-10A1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD, 553768) was used in flow cytometry on mouse samples . Exp Mol Med (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse
BD Biosciences B7 1 antibody (BD Biosciences, 16-10A1) was used in flow cytometry on mouse samples . Int Immunol (2014) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; mouse; 1:100
BD Biosciences B7 1 antibody (BD Biosciences, 553768) was used in flow cytometry on mouse samples at 1:100. Nat Med (2013) ncbi
hamsters monoclonal (16-10A1)
  • flow cytometry; human
BD Biosciences B7 1 antibody (BD Biosciences, 553768) was used in flow cytometry on human samples . J Immunol (2010) ncbi
Articles Reviewed
  1. Que W, Ma K, Hu X, Guo W, Li X. Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells. Sci Adv. 2022;8:eabo4413 pubmed publisher
  2. Pi xf1 eros A, Kulkarni A, Gao H, Orr K, Glenn L, Huang F, et al. Proinflammatory signaling in islet β cells propagates invasion of pathogenic immune cells in autoimmune diabetes. Cell Rep. 2022;39:111011 pubmed publisher
  3. Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, et al. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nat Commun. 2022;13:2176 pubmed publisher
  4. Bartsch P, Kilian C, Hellmig M, Paust H, Borchers A, Sivayoganathan A, et al. Th17 cell plasticity towards a T-bet-dependent Th1 phenotype is required for bacterial control in Staphylococcus aureus infection. PLoS Pathog. 2022;18:e1010430 pubmed publisher
  5. Zhang Y, Huo F, Cao Q, Jia R, Huang Q, Wang Z, et al. FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. J Immunother Cancer. 2022;10: pubmed publisher
  6. Günes Günsel G, Conlon T, Jeridi A, Kim R, Ertuz Z, Lang N, et al. The arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD. Nat Commun. 2022;13:1303 pubmed publisher
  7. Araujo A, Abaurrea A, Azcoaga P, L xf3 pez Velazco J, Manzano S, Rodriguez J, et al. Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment. J Clin Invest. 2022;132: pubmed publisher
  8. Lopes N, Boucherit N, Santamaria J, Provin N, Charaix J, Ferrier P, et al. Thymocytes trigger self-antigen-controlling pathways in immature medullary thymic epithelial stages. elife. 2022;11: pubmed publisher
  9. Zhou Q, Liang J, Yang T, Liu J, Li B, Li Y, et al. Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer. EMBO Mol Med. 2022;14:e14502 pubmed publisher
  10. Stoff M, Ebbecke T, Ciurkiewicz M, Pavasutthipaisit S, Mayer Lambertz S, St xf6 rk T, et al. C-type lectin receptor DCIR contributes to hippocampal injury in acute neurotropic virus infection. Sci Rep. 2021;11:23819 pubmed publisher
  11. Zhu Y, Elsheikha H, Wang J, Fang S, He J, Zhu X, et al. Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors. J Immunother Cancer. 2021;9: pubmed publisher
  12. Liu H, Pedros C, Kong K, Canonigo Balancio A, Xue W, Altman A. Leveraging the Treg-intrinsic CTLA4-PKCη signaling pathway for cancer immunotherapy. J Immunother Cancer. 2021;9: pubmed publisher
  13. Zhang X, Chang A, Zou Y, Xu H, Cui J, Chen Z, et al. Aspirin Attenuates Cardiac Allograft Rejection by Inhibiting the Maturation of Dendritic Cells via the NF-κB Signaling Pathway. Front Pharmacol. 2021;12:706748 pubmed publisher
  14. Neumann S, Campbell K, Woodall M, Evans M, Clarkson A, Young S. Obesity Has a Systemic Effect on Immune Cells in Naïve and Cancer-Bearing Mice. Int J Mol Sci. 2021;22: pubmed publisher
  15. Guo L, Xie H, Zhang Z, Wang Z, Peng S, Niu Y, et al. Fusion Protein Vaccine Based on Ag85B and STEAP1 Induces a Protective Immune Response against Prostate Cancer. Vaccines (Basel). 2021;9: pubmed publisher
  16. Funk K, Arutyunov A, Desai P, White J, Soung A, Rosen S, et al. Decreased antiviral immune response within the central nervous system of aged mice is associated with increased lethality of West Nile virus encephalitis. Aging Cell. 2021;20:e13412 pubmed publisher
  17. Hutton C, Heider F, Blanco Gómez A, Banyard A, Kononov A, Zhang X, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;: pubmed publisher
  18. Bruand M, Barras D, Mina M, Ghisoni E, Morotti M, Lanitis E, et al. Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING. Cell Rep. 2021;36:109412 pubmed publisher
  19. Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, et al. Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy. J Immunother Cancer. 2021;9: pubmed publisher
  20. Tian X, Wang Y, Lu Y, Wang W, Du J, Chen S, et al. Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19. Cell Death Dis. 2021;12:646 pubmed publisher
  21. Nakatani T, Tsujimoto K, Park J, Jo T, Kimura T, Hayama Y, et al. The lysosomal Ragulator complex plays an essential role in leukocyte trafficking by activating myosin II. Nat Commun. 2021;12:3333 pubmed publisher
  22. Okunuki Y, Tabor S, Lee M, Connor K. CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation. Front Immunol. 2021;12:680568 pubmed publisher
  23. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  24. Borkner L, Curham L, Wilk M, Moran B, Mills K. IL-17 mediates protective immunity against nasal infection with Bordetella pertussis by mobilizing neutrophils, especially Siglec-F+ neutrophils. Mucosal Immunol. 2021;14:1183-1202 pubmed publisher
  25. Go D, Lee S, Lee S, Woo S, Kim K, Kim K, et al. Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis. Cell Mol Gastroenterol Hepatol. 2021;12:715-739 pubmed publisher
  26. Chen J, Cao X, Li B, Zhao Z, Chen S, Lai S, et al. Warburg Effect Is a Cancer Immune Evasion Mechanism Against Macrophage Immunosurveillance. Front Immunol. 2020;11:621757 pubmed publisher
  27. Li Y, Sun Y, Kulke M, Hechler T, Van der Jeught K, Dong T, et al. Targeted immunotherapy for HER2-low breast cancer with 17p loss. Sci Transl Med. 2021;13: pubmed publisher
  28. Ali S, Borin T, Piranlioglu R, Ara R, Lebedyeva I, Angara K, et al. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study. PLoS ONE. 2021;16:e0246646 pubmed publisher
  29. Chen J, Sivan U, Tan S, Lippo L, De Angelis J, Labella R, et al. High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging. Sci Adv. 2021;7: pubmed publisher
  30. Yang Y, Li X, Ma Z, Wang C, Yang Q, Byrne Steele M, et al. CTLA-4 expression by B-1a B cells is essential for immune tolerance. Nat Commun. 2021;12:525 pubmed publisher
  31. Rudloff S, Janot M, Rodriguez S, Dessalle K, Jahnen Dechent W, Huynh Do U. Fetuin-A is a HIF target that safeguards tissue integrity during hypoxic stress. Nat Commun. 2021;12:549 pubmed publisher
  32. Khaw Y, Majid D, Oh S, Kang E, Inoue M. Early-life-trauma triggers interferon-β resistance and neurodegeneration in a multiple sclerosis model via downregulated β1-adrenergic signaling. Nat Commun. 2021;12:105 pubmed publisher
  33. Meryk A, Grasse M, Balasco L, Kapferer W, Grubeck Loebenstein B, Pangrazzi L. Antioxidants N-Acetylcysteine and Vitamin C Improve T Cell Commitment to Memory and Long-Term Maintenance of Immunological Memory in Old Mice. Antioxidants (Basel). 2020;9: pubmed publisher
  34. Weng X, Zhao H, Guan Q, Shi G, Feng S, Gleave M, et al. Clusterin regulates macrophage expansion, polarization and phagocytic activity in response to inflammation in the kidneys. Immunol Cell Biol. 2021;99:274-287 pubmed publisher
  35. Zhao L, Hu S, Davila M, Yang J, Lin Y, Albanese J, et al. Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation. Mucosal Immunol. 2021;14:420-430 pubmed publisher
  36. Cignarella F, Filipello F, Bollman B, Cantoni C, Locca A, Mikesell R, et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. 2020;140:513-534 pubmed publisher
  37. Kim E, Woodruff M, Grigoryan L, Maier B, Lee S, Mandal P, et al. Squalene emulsion-based vaccine adjuvants stimulate CD8 T cell, but not antibody responses, through a RIPK3-dependent pathway. elife. 2020;9: pubmed publisher
  38. Zheng D, Gao F, Cheng Q, Bao P, Dong X, Fan J, et al. A vaccine-based nanosystem for initiating innate immunity and improving tumor immunotherapy. Nat Commun. 2020;11:1985 pubmed publisher
  39. Stebegg M, Bignon A, Hill D, Silva Cayetano A, Krueger C, Vanderleyden I, et al. Rejuvenating conventional dendritic cells and T follicular helper cell formation after vaccination. elife. 2020;9: pubmed publisher
  40. Chao Y, Liang C, Tao H, Du Y, Wu D, Dong Z, et al. Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses. Sci Adv. 2020;6:eaaz4204 pubmed publisher
  41. Luker A, Graham L, Smith T, Camarena C, Zellner M, Gilmer J, et al. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. BMC Immunol. 2020;21:8 pubmed publisher
  42. Aslan K, Turco V, Blobner J, Sonner J, Liuzzi A, Núñez N, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931 pubmed publisher
  43. Martinez L, Garcia G, Contreras D, Gong D, Sun R, Arumugaswami V. Zika Virus Mucosal Infection Provides Protective Immunity. J Virol. 2020;94: pubmed publisher
  44. Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, et al. Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties. Nat Commun. 2020;11:609 pubmed publisher
  45. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  46. Canel M, Taggart D, Sims A, Lonergan D, Waizenegger I, Serrels A. T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity. elife. 2020;9: pubmed publisher
  47. Tencerova M, Rendina Ruedy E, Neess D, Færgeman N, Figeac F, Ali D, et al. Metabolic programming determines the lineage-differentiation fate of murine bone marrow stromal progenitor cells. Bone Res. 2019;7:35 pubmed publisher
  48. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  49. Wolf Y, Bartok O, Patkar S, Eli G, Cohen S, Litchfield K, et al. UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell. 2019;179:219-235.e21 pubmed publisher
  50. Kodumudi K, Ramamoorthi G, Snyder C, Basu A, Jia Y, Awshah S, et al. Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. Front Immunol. 2019;10:1939 pubmed publisher
  51. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  52. Koike T, Harada K, Horiuchi S, Kitamura D. The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets. elife. 2019;8: pubmed publisher
  53. Oh J, Iijima N, Song E, Lu P, Klein J, Jiang R, et al. Migrant memory B cells secrete luminal antibody in the vagina. Nature. 2019;: pubmed publisher
  54. Sivaram N, McLaughlin P, Han H, Petrenko O, Jiang Y, Ballou L, et al. Tumor-intrinsic PIK3CA represses tumor immunogenecity in a model of pancreatic cancer. J Clin Invest. 2019;130: pubmed publisher
  55. Humeniuk P, Geiselhart S, Battin C, Webb T, Steinberger P, Paster W, et al. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019;9:7426 pubmed publisher
  56. Miao Y, Yang H, Levorse J, Yuan S, Polak L, Sribour M, et al. Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells. Cell. 2019;177:1172-1186.e14 pubmed publisher
  57. Mizuno R, Sugiura D, Shimizu K, Maruhashi T, Watada M, Okazaki I, et al. PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation. Front Immunol. 2019;10:630 pubmed publisher
  58. Sugiura D, Maruhashi T, Okazaki I, Shimizu K, Maeda T, Takemoto T, et al. Restriction of PD-1 function by cis-PD-L1/CD80 interactions is required for optimal T cell responses. Science. 2019;364:558-566 pubmed publisher
  59. Knox T, Sahakian E, Banik D, Hadley M, Palmer E, Noonepalle S, et al. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells. Sci Rep. 2019;9:6136 pubmed publisher
  60. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  61. Lee Y, Ju J, Shon W, Oh S, Min C, Kang M, et al. Skewed Dendritic Cell Differentiation of MyD88-Deficient Donor Bone Marrow Cells, Instead of Massive Expansion as Myeloid-Derived Suppressor Cells, Aggravates GVHD. Immune Netw. 2018;18:e44 pubmed publisher
  62. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed publisher
  63. Düsedau H, Kleveman J, Figueiredo C, Biswas A, Steffen J, Kliche S, et al. p75NTR regulates brain mononuclear cell function and neuronal structure in Toxoplasma infection-induced neuroinflammation. Glia. 2019;67:193-211 pubmed publisher
  64. Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin G, Shurin M, et al. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019;116:1361-1369 pubmed publisher
  65. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  66. Vega Angeles V, Terrazas L, Ledesma Soto Y, Jimenez L, Landa A. Taenia solium glutathione transferase fraction activates macrophages and favors the development of Th1-type response. Biosci Rep. 2019;39: pubmed publisher
  67. Magallanes Puebla A, Espinosa Cueto P, López Marín L, Mancilla R. Mycobacterial glycolipid Di-O-acyl trehalose promotes a tolerogenic profile in dendritic cells. PLoS ONE. 2018;13:e0207202 pubmed publisher
  68. Tordesillas L, Lozano Ojalvo D, Dunkin D, Mondoulet L, Agudo J, Merad M, et al. PDL2+ CD11b+ dermal dendritic cells capture topical antigen through hair follicles to prime LAP+ Tregs. Nat Commun. 2018;9:5238 pubmed publisher
  69. Kiyohara H, Sujino T, Teratani T, Miyamoto K, Arai M, Nomura E, et al. Toll-Like Receptor 7 Agonist-Induced Dermatitis Causes Severe Dextran Sulfate Sodium Colitis by Altering the Gut Microbiome and Immune Cells. Cell Mol Gastroenterol Hepatol. 2019;7:135-156 pubmed publisher
  70. Aarts S, Seijkens T, Kusters P, Van Tiel C, Reiche M, den Toom M, et al. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis. J Pathol. 2019;247:471-480 pubmed publisher
  71. Casagrande F, de Souza Ferreira S, Nunes F, Romera L, Dos Santos S, Tessaro F, et al. Insulin Modulates Paracoccidioides brasiliensis-Induced Inflammation by Restoring the Populations of NK Cells, Dendritic Cells, and B Lymphocytes in Lungs. J Diabetes Res. 2018;2018:6209694 pubmed publisher
  72. Montero Herradón S, García Ceca J, Zapata A. Altered Maturation of Medullary TEC in EphB-Deficient Thymi Is Recovered by RANK Signaling Stimulation. Front Immunol. 2018;9:1020 pubmed publisher
  73. Yao Y, Huang W, Li X, Li X, Qian J, Han H, et al. Tespa1 Deficiency Dampens Thymus-Dependent B-Cell Activation and Attenuates Collagen-Induced Arthritis in Mice. Front Immunol. 2018;9:965 pubmed publisher
  74. Du X, Wen J, Wang Y, Karmaus P, Khatamian A, Tan H, et al. Hippo/Mst signalling couples metabolic state and immune function of CD8α+ dendritic cells. Nature. 2018;558:141-145 pubmed publisher
  75. Grist J, Marro B, Skinner D, Syage A, Worne C, Doty D, et al. Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment. Eur J Immunol. 2018;48:1199-1210 pubmed publisher
  76. Mencarelli A, Khameneh H, Fric J, Vacca M, El Daker S, Janela B, et al. Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis. Nat Commun. 2018;9:1102 pubmed publisher
  77. Pedros C, Canonigo Balancio A, Kong K, Altman A. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity. JCI Insight. 2017;2: pubmed publisher
  78. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  79. Billerbeck E, Wolfisberg R, Fahnøe U, Xiao J, Quirk C, Luna J, et al. Mouse models of acute and chronic hepacivirus infection. Science. 2017;357:204-208 pubmed publisher
  80. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  81. Cao Y, Zhang E, Yang J, Yang Y, Yu J, Xiao Y, et al. Frontline Science: Nasal epithelial GM-CSF contributes to TLR5-mediated modulation of airway dendritic cells and subsequent IgA response. J Leukoc Biol. 2017;102:575-587 pubmed publisher
  82. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  83. Shrestha B, You D, Saravia J, Siefker D, Jaligama S, Lee G, et al. IL-4R? on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection. J Leukoc Biol. 2017;102:153-161 pubmed publisher
  84. Lehmann C, Baranska A, Heidkamp G, Heger L, Neubert K, Lühr J, et al. DC subset-specific induction of T cell responses upon antigen uptake via Fc? receptors in vivo. J Exp Med. 2017;214:1509-1528 pubmed publisher
  85. Inoue T, Shinnakasu R, Ise W, Kawai C, Egawa T, Kurosaki T. The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help. J Exp Med. 2017;214:1181-1198 pubmed publisher
  86. Kogo H, Shimizu M, Negishi Y, Uchida E, Takahashi H. Suppression of murine tumour growth through CD8+ cytotoxic T lymphocytes via activated DEC-205+ dendritic cells by sequential administration of ?-galactosylceramide in vivo. Immunology. 2017;151:324-339 pubmed publisher
  87. Barthels C, Ogrinc A, Steyer V, Meier S, Simon F, Wimmer M, et al. CD40-signalling abrogates induction of RORγt+ Treg cells by intestinal CD103+ DCs and causes fatal colitis. Nat Commun. 2017;8:14715 pubmed publisher
  88. Wang H, Mo L, Xiao X, An S, Liu X, Ba J, et al. Pplase of Dermatophagoides farinae promotes ovalbumin-induced airway allergy by modulating the functions of dendritic cells in a mouse model. Sci Rep. 2017;7:43322 pubmed publisher
  89. Komegae E, Souza T, Grund L, Lima C, Lopes Ferreira M. Multiple functional therapeutic effects of TnP: A small stable synthetic peptide derived from fish venom in a mouse model of multiple sclerosis. PLoS ONE. 2017;12:e0171796 pubmed publisher
  90. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed publisher
  91. Hwang I, Kim K, Choi S, Lomunova M. Potentiation of T Cell Stimulatory Activity by Chemical Fixation of a Weak Peptide-MHC Complex. Mol Cells. 2017;40:24-36 pubmed publisher
  92. van Nieuwenhuijze A, Dooley J, Humblet Baron S, Sreenivasan J, Koenders M, Schlenner S, et al. Defective germinal center B-cell response and reduced arthritic pathology in microRNA-29a-deficient mice. Cell Mol Life Sci. 2017;74:2095-2106 pubmed publisher
  93. Weindel C, Richey L, Mehta A, Shah M, Huber B. Autophagy in Dendritic Cells and B Cells Is Critical for the Inflammatory State of TLR7-Mediated Autoimmunity. J Immunol. 2017;198:1081-1092 pubmed publisher
  94. Khameneh H, Ho A, Spreafico R, Derks H, Quek H, Mortellaro A. The Syk-NFAT-IL-2 Pathway in Dendritic Cells Is Required for Optimal Sterile Immunity Elicited by Alum Adjuvants. J Immunol. 2017;198:196-204 pubmed
  95. Lund M, Greer J, Dixit A, Alvarado R, McCauley Winter P, To J, et al. A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Sci Rep. 2016;6:37789 pubmed publisher
  96. Tahiri H, Omri S, Yang C, Duhamel F, Samarani S, Ahmad A, et al. Lymphocytic Microparticles Modulate Angiogenic Properties of Macrophages in Laser-induced Choroidal Neovascularization. Sci Rep. 2016;6:37391 pubmed publisher
  97. Hammer A, Yang G, Friedrich J, Kovacs A, Lee D, Grave K, et al. Role of the receptor Mas in macrophage-mediated inflammation in vivo. Proc Natl Acad Sci U S A. 2016;113:14109-14114 pubmed
  98. Takács E, Boto P, Simo E, Csuth T, Toth B, Raveh Amit H, et al. Immunogenic Dendritic Cell Generation from Pluripotent Stem Cells by Ectopic Expression of Runx3. J Immunol. 2017;198:239-248 pubmed
  99. Hirako I, Ataide M, Faustino L, Assis P, Sorensen E, Ueta H, et al. Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria. Nat Commun. 2016;7:13277 pubmed publisher
  100. Chu V, Graf R, Wirtz T, Weber T, Favret J, Li X, et al. Efficient CRISPR-mediated mutagenesis in primary immune cells using CrispRGold and a C57BL/6 Cas9 transgenic mouse line. Proc Natl Acad Sci U S A. 2016;113:12514-12519 pubmed
  101. Klotz L, Kuzmanov I, Hucke S, Gross C, Posevitz V, Dreykluft A, et al. B7-H1 shapes T-cell-mediated brain endothelial cell dysfunction and regional encephalitogenicity in spontaneous CNS autoimmunity. Proc Natl Acad Sci U S A. 2016;113:E6182-E6191 pubmed
  102. Bemark M, Hazanov H, Strömberg A, Komban R, Holmqvist J, Köster S, et al. Limited clonal relatedness between gut IgA plasma cells and memory B cells after oral immunization. Nat Commun. 2016;7:12698 pubmed publisher
  103. Papadaki G, Kambas K, Choulaki C, Vlachou K, Drakos E, Bertsias G, et al. Neutrophil extracellular traps exacerbate Th1-mediated autoimmune responses in rheumatoid arthritis by promoting DC maturation. Eur J Immunol. 2016;46:2542-2554 pubmed publisher
  104. Papp S, Moderzynski K, Rauch J, Heine L, Kuehl S, Richardt U, et al. Liver Necrosis and Lethal Systemic Inflammation in a Murine Model of Rickettsia typhi Infection: Role of Neutrophils, Macrophages and NK Cells. PLoS Negl Trop Dis. 2016;10:e0004935 pubmed publisher
  105. Kouwenberg M, Jacobs C, van der Vlag J, Hilbrands L. Allostimulatory Effects of Dendritic Cells with Characteristic Features of a Regulatory Phenotype. PLoS ONE. 2016;11:e0159986 pubmed publisher
  106. Zhao Y, Chu X, Chen J, Wang Y, Gao S, Jiang Y, et al. Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells. Nat Commun. 2016;7:12368 pubmed publisher
  107. Chow K, Delconte R, Huntington N, Tarlinton D, Sutherland R, Zhan Y, et al. Innate Allorecognition Results in Rapid Accumulation of Monocyte-Derived Dendritic Cells. J Immunol. 2016;197:2000-8 pubmed publisher
  108. Veinotte L, Gebremeskel S, Johnston B. CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFN? production and tumor control. Oncoimmunology. 2016;5:e1160979 pubmed publisher
  109. Raguz J, Jerić I, Niault T, Nowacka J, Kuzet S, Rupp C, et al. Epidermal RAF prevents allergic skin disease. elife. 2016;5: pubmed publisher
  110. Wang S, Xia P, Chen Y, Huang G, Xiong Z, Liu J, et al. Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection. Immunity. 2016;45:131-44 pubmed publisher
  111. Engelmann R, Biemelt A, Cordshagen A, Johl A, Kuthning D, Müller Hilke B. The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse. PLoS ONE. 2016;11:e0158773 pubmed publisher
  112. Ahmad F, Chung Y, Tang Y, Hockman S, Liu S, Khan Y, et al. Phosphodiesterase 3B (PDE3B) regulates NLRP3 inflammasome in adipose tissue. Sci Rep. 2016;6:28056 pubmed publisher
  113. Lo T, Silveira P, Fromm P, Verma N, Vu P, Kupresanin F, et al. Characterization of the Expression and Function of the C-Type Lectin Receptor CD302 in Mice and Humans Reveals a Role in Dendritic Cell Migration. J Immunol. 2016;197:885-98 pubmed publisher
  114. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  115. Chikh G, Luu R, Patel S, Davis H, Weeratna R. Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences. Vaccines (Basel). 2016;4: pubmed publisher
  116. Xu S, Tao Z, Hai B, Liang H, Shi Y, Wang T, et al. miR-424(322) reverses chemoresistance via T-cell immune response activation by blocking the PD-L1 immune checkpoint. Nat Commun. 2016;7:11406 pubmed publisher
  117. Xu X, Meng Q, Erben U, Wang P, Glauben R, Kuhl A, et al. Myeloid-derived suppressor cells promote B-cell production of IgA in a TNFR2-dependent manner. Cell Mol Immunol. 2017;14:597-606 pubmed publisher
  118. Jain N, Khullar B, Oswal N, Banoth B, Joshi P, Ravindran B, et al. TLR-mediated albuminuria needs TNF?-mediated cooperativity between TLRs present in hematopoietic tissues and CD80 present on non-hematopoietic tissues in mice. Dis Model Mech. 2016;9:707-17 pubmed publisher
  119. Salao K, Jiang L, Li H, Tsai V, Husaini Y, Curmi P, et al. CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis. Biol Open. 2016;5:620-30 pubmed publisher
  120. Uto T, Fukaya T, Takagi H, Arimura K, Nakamura T, Kojima N, et al. Clec4A4 is a regulatory receptor for dendritic cells that impairs inflammation and T-cell immunity. Nat Commun. 2016;7:11273 pubmed publisher
  121. Ufimtseva E. Differences between Mycobacterium-Host Cell Relationships in Latent Tuberculous Infection of Mice Ex Vivo and Mycobacterial Infection of Mouse Cells In Vitro. J Immunol Res. 2016;2016:4325646 pubmed publisher
  122. Lee S, Hong S, Verma V, Lee Y, Duong T, Jeong K, et al. Flagellin is a strong vaginal adjuvant of a therapeutic vaccine for genital cancer. Oncoimmunology. 2016;5:e1081328 pubmed
  123. Kawano M, Tanaka K, Itonaga I, Iwasaki T, Miyazaki M, Ikeda S, et al. Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma. Oncol Lett. 2016;11:2169-2175 pubmed
  124. Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher
  125. Leeth C, Racine J, Chapman H, Arpa B, Carrillo J, Carrascal J, et al. B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes. 2016;65:1977-1987 pubmed publisher
  126. Haribhai D, Ziegelbauer J, Jia S, Upchurch K, Yan K, Schmitt E, et al. Alternatively Activated Macrophages Boost Induced Regulatory T and Th17 Cell Responses during Immunotherapy for Colitis. J Immunol. 2016;196:3305-17 pubmed publisher
  127. Ying W, Tseng A, Chang R, Wang H, Lin Y, Kanameni S, et al. miR-150 regulates obesity-associated insulin resistance by controlling B cell functions. Sci Rep. 2016;6:20176 pubmed publisher
  128. Lasigliè D, Boero S, Bauer I, Morando S, Damonte P, Cea M, et al. Sirt6 regulates dendritic cell differentiation, maturation, and function. Aging (Albany NY). 2016;8:34-49 pubmed
  129. McCubbrey A, Nelson J, Stolberg V, Blakely P, McCloskey L, Janssen W, et al. MicroRNA-34a Negatively Regulates Efferocytosis by Tissue Macrophages in Part via SIRT1. J Immunol. 2016;196:1366-75 pubmed publisher
  130. Mikyšková R, Štěpánek I, Indrová M, Bieblová J, Šímová J, Truxová I, et al. Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int J Oncol. 2016;48:953-64 pubmed publisher
  131. Traka M, Podojil J, McCarthy D, Miller S, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci. 2016;19:65-74 pubmed publisher
  132. Schachtner H, Weimershaus M, Stache V, Plewa N, Legler D, Höpken U, et al. Loss of Gadkin Affects Dendritic Cell Migration In Vitro. PLoS ONE. 2015;10:e0143883 pubmed publisher
  133. Onodera T, Fukuhara A, Jang M, Shin J, Aoi K, Kikuta J, et al. Adipose tissue macrophages induce PPARγ-high FOXP3(+) regulatory T cells. Sci Rep. 2015;5:16801 pubmed publisher
  134. Fontinha D, Lopes F, Marques S, Alenquer M, Simas J. Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS ONE. 2015;10:e0142540 pubmed publisher
  135. Riquelme S, Pogu J, Anegon I, Bueno S, Kalergis A. Carbon monoxide impairs mitochondria-dependent endosomal maturation and antigen presentation in dendritic cells. Eur J Immunol. 2015;45:3269-88 pubmed publisher
  136. Patel J, Vartabedian V, Bozeman E, Caoyonan B, Srivatsan S, Pack C, et al. Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth. Biomaterials. 2016;74:231-44 pubmed publisher
  137. Sun L, Sun C, Liang Z, Li H, Chen L, Luo H, et al. FSP1(+) fibroblast subpopulation is essential for the maintenance and regeneration of medullary thymic epithelial cells. Sci Rep. 2015;5:14871 pubmed publisher
  138. Sun L, Hua Y, Vergarajauregui S, Diab H, Puertollano R. Novel Role of TRPML2 in the Regulation of the Innate Immune Response. J Immunol. 2015;195:4922-32 pubmed publisher
  139. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  140. Buerger S, Herrmann V, Mundt S, Trautwein N, Groettrup M, Basler M. The Ubiquitin-like Modifier FAT10 Is Selectively Expressed in Medullary Thymic Epithelial Cells and Modifies T Cell Selection. J Immunol. 2015;195:4106-16 pubmed publisher
  141. Sei J, Haskett S, Kaminsky L, Lin E, Truckenmiller M, Bellone C, et al. Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation. PLoS Pathog. 2015;11:e1004941 pubmed publisher
  142. Kamachi F, Isshiki T, Harada N, Akiba H, Miyake S. ICOS promotes group 2 innate lymphoid cell activation in lungs. Biochem Biophys Res Commun. 2015;463:739-45 pubmed publisher
  143. Holtzhausen A, Zhao F, Evans K, Tsutsui M, Orabona C, Tyler D, et al. Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy. Cancer Immunol Res. 2015;3:1082-95 pubmed publisher
  144. Liechtenstein T, Perez Janices N, Blanco Luquin I, Goyvaerts C, Schwarze J, Dufait I, et al. Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using ex vivo myeloid-derived suppressor cells as a readout of therapeutic efficacy. Oncoimmunology. 2014;3:e945378 pubmed
  145. Zeng S, Wang L, Li P, Wang W, Yang J. Mesenchymal stem cells abrogate experimental asthma by altering dendritic cell function. Mol Med Rep. 2015;12:2511-20 pubmed publisher
  146. Carmi Y, Spitzer M, Linde I, Burt B, Prestwood T, Perlman N, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521:99-104 pubmed publisher
  147. Sharma S, Chintala N, Vadrevu S, Patel J, Karbowniczek M, Markiewski M. Pulmonary alveolar macrophages contribute to the premetastatic niche by suppressing antitumor T cell responses in the lungs. J Immunol. 2015;194:5529-38 pubmed publisher
  148. Kolan S, Boman A, Matozaki T, Lejon K, Oldenborg P. Lack of non-hematopoietic SIRPα signaling disturbs the splenic marginal zone architecture resulting in accumulation and displacement of marginal zone B cells. Biochem Biophys Res Commun. 2015;460:645-50 pubmed publisher
  149. Jobsri J, Allen A, Rajagopal D, Shipton M, Kanyuka K, Lomonossoff G, et al. Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody. PLoS ONE. 2015;10:e0118096 pubmed publisher
  150. Pannu J, Belle J, Forster M, Duerr C, Shen S, Kane L, et al. Ubiquitin specific protease 21 is dispensable for normal development, hematopoiesis and lymphocyte differentiation. PLoS ONE. 2015;10:e0117304 pubmed publisher
  151. Sun H, Zhang J, Chen F, Chen X, Zhou Z, Wang H. Activation of RAW264.7 macrophages by the polysaccharide from the roots of Actinidia eriantha and its molecular mechanisms. Carbohydr Polym. 2015;121:388-402 pubmed publisher
  152. Stack G, Jones E, Marsden M, Stacey M, Snelgrove R, Lacaze P, et al. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog. 2015;11:e1004641 pubmed publisher
  153. Jing W, Gershan J, Weber J, Tlomak D, McOlash L, Sabatos Peyton C, et al. Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma. J Immunother Cancer. 2015;3:2 pubmed publisher
  154. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed publisher
  155. Rattay K, Claude J, Rezavandy E, Matt S, Hofmann T, Kyewski B, et al. Homeodomain-interacting protein kinase 2, a novel autoimmune regulator interaction partner, modulates promiscuous gene expression in medullary thymic epithelial cells. J Immunol. 2015;194:921-8 pubmed publisher
  156. Skripuletz T, Manzel A, Gropengießer K, Schäfer N, Gudi V, Singh V, et al. Pivotal role of choline metabolites in remyelination. Brain. 2015;138:398-413 pubmed publisher
  157. Ikeda T, Hirata S, Takamatsu K, Haruta M, Tsukamoto H, Ito T, et al. Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells. PLoS ONE. 2014;9:e115198 pubmed publisher
  158. White C, Villarino N, Sloan S, Ganusov V, Schmidt N. Plasmodium suppresses expansion of T cell responses to heterologous infections. J Immunol. 2015;194:697-708 pubmed publisher
  159. Yin Y, Qin T, Wang X, Lin J, Yu Q, Yang Q. CpG DNA assists the whole inactivated H9N2 influenza virus in crossing the intestinal epithelial barriers via transepithelial uptake of dendritic cell dendrites. Mucosal Immunol. 2015;8:799-814 pubmed publisher
  160. Frossard C, Asigbetse K, Burger D, Eigenmann P. Gut T cell receptor-γδ(+) intraepithelial lymphocytes are activated selectively by cholera toxin to break oral tolerance in mice. Clin Exp Immunol. 2015;180:118-30 pubmed publisher
  161. Thauland T, Koguchi Y, Dustin M, Parker D. CD28-CD80 interactions control regulatory T cell motility and immunological synapse formation. J Immunol. 2014;193:5894-903 pubmed publisher
  162. McDonnell A, Lesterhuis W, Khong A, Nowak A, Lake R, Currie A, et al. Tumor-infiltrating dendritic cells exhibit defective cross-presentation of tumor antigens, but is reversed by chemotherapy. Eur J Immunol. 2015;45:49-59 pubmed publisher
  163. Škrnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed publisher
  164. Wei F, Yang D, Tewary P, Li Y, Li S, Chen X, et al. The Alarmin HMGN1 contributes to antitumor immunity and is a potent immunoadjuvant. Cancer Res. 2014;74:5989-98 pubmed publisher
  165. Dai M, Yip Y, Hellstrom I, Hellstrom K. Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. Clin Cancer Res. 2015;21:1127-38 pubmed publisher
  166. Rauen J, Kreer C, Paillard A, van Duikeren S, Benckhuijsen W, Camps M, et al. Enhanced cross-presentation and improved CD8+ T cell responses after mannosylation of synthetic long peptides in mice. PLoS ONE. 2014;9:e103755 pubmed publisher
  167. Penaloza MacMaster P, Kamphorst A, Wieland A, Araki K, Iyer S, West E, et al. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J Exp Med. 2014;211:1905-18 pubmed publisher
  168. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  169. Siurala M, Bramante S, Vassilev L, Hirvinen M, Parviainen S, Tähtinen S, et al. Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma. Int J Cancer. 2015;136:945-54 pubmed publisher
  170. Assi H, Espinosa J, Suprise S, SOFRONIEW M, Doherty R, Zamler D, et al. Assessing the role of STAT3 in DC differentiation and autologous DC immunotherapy in mouse models of GBM. PLoS ONE. 2014;9:e96318 pubmed publisher
  171. Qian L, Zhang M, Wu S, Zhong Y, Van Tol E, Cai W. Alkylglycerols modulate the proliferation and differentiation of non-specific agonist and specific antigen-stimulated splenic lymphocytes. PLoS ONE. 2014;9:e96207 pubmed publisher
  172. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  173. Hirayama T, Asano Y, Iida H, Watanabe T, Nakamura T, Goitsuka R. Meis1 is required for the maintenance of postnatal thymic epithelial cells. PLoS ONE. 2014;9:e89885 pubmed publisher
  174. Martins K, Steffens J, Van Tongeren S, Wells J, Bergeron A, Dickson S, et al. Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PLoS ONE. 2014;9:e89735 pubmed publisher
  175. Ramakrishnan R, Tyurin V, Tuyrin V, Veglia F, Condamine T, Amoscato A, et al. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. J Immunol. 2014;192:2920-31 pubmed publisher
  176. Jin Y, Wi H, Choi M, Hong S, Bae Y. Regulation of anti-inflammatory cytokines IL-10 and TGF-? in mouse dendritic cells through treatment with Clonorchis sinensis crude antigen. Exp Mol Med. 2014;46:e74 pubmed publisher
  177. Xia S, Wei J, Wang J, Sun H, Zheng W, Li Y, et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. J Leukoc Biol. 2014;95:733-742 pubmed
  178. Iwata A, Kawashima S, Kobayashi M, Okubo A, Kawashima H, Suto A, et al. Th2-type inflammation instructs inflammatory dendritic cells to induce airway hyperreactivity. Int Immunol. 2014;26:103-14 pubmed publisher
  179. Harimoto H, Shimizu M, Nakagawa Y, Nakatsuka K, Wakabayashi A, Sakamoto C, et al. Inactivation of tumor-specific CD8? CTLs by tumor-infiltrating tolerogenic dendritic cells. Immunol Cell Biol. 2013;91:545-55 pubmed publisher
  180. Bittner S, Ruck T, Schuhmann M, Herrmann A, Moha Ou Maati H, Bobak N, et al. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161-5 pubmed publisher
  181. Khan A, Fu H, Tan L, Harper J, Beutelspacher S, Larkin D, et al. Dendritic cell modification as a route to inhibiting corneal graft rejection by the indirect pathway of allorecognition. Eur J Immunol. 2013;43:734-46 pubmed publisher
  182. Purtha W, Tedder T, Johnson S, Bhattacharya D, Diamond M. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med. 2011;208:2599-606 pubmed publisher
  183. Tait E, Jordan K, Dupont C, Harris T, Gregg B, Wilson E, et al. Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol. 2010;185:1502-12 pubmed publisher
  184. Charles E, Joshi S, Ash J, Fox B, Farris A, Bzik D, et al. CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1. Infect Immun. 2010;78:3484-92 pubmed publisher
  185. Schuhmann M, Stegner D, Berna Erro A, Bittner S, Braun A, Kleinschnitz C, et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol. 2010;184:1536-42 pubmed publisher
  186. Ellestad K, Tsutsui S, Noorbakhsh F, Warren K, Yong V, Pittman Q, et al. Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol. 2009;183:298-309 pubmed publisher
  187. Kiesel J, Buchwald Z, Aurora R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J Immunol. 2009;182:5477-87 pubmed publisher
  188. Hamazaki Y, Fujita H, Kobayashi T, Choi Y, Scott H, Matsumoto M, et al. Medullary thymic epithelial cells expressing Aire represent a unique lineage derived from cells expressing claudin. Nat Immunol. 2007;8:304-11 pubmed
  189. Hoffmann P, Kench J, Vondracek A, Kruk E, Daleke D, Jordan M, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393-404 pubmed
  190. Jenkins S, Mountford A. Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infect Immun. 2005;73:395-402 pubmed
  191. Freyschmidt E, Alonso A, Hartmann G, Gissmann L. Activation of dendritic cells and induction of T cell responses by HPV 16 L1/E7 chimeric virus-like particles are enhanced by CpG ODN or sorbitol. Antivir Ther. 2004;9:479-89 pubmed
  192. Zhang T, He X, Tsang T, Harris D. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function. Cancer Gene Ther. 2004;11:487-96 pubmed
  193. Morin J, Faideau B, Gagnerault M, Lepault F, Boitard C, Boudaly S. Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice. Clin Exp Immunol. 2003;134:388-95 pubmed
  194. Cabatingan M, Schmidt M, Sen R, Woodland R. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol. 2002;169:6795-805 pubmed
  195. Denda Nagai K, Kubota N, Tsuiji M, Kamata M, Irimura T. Macrophage C-type lectin on bone marrow-derived immature dendritic cells is involved in the internalization of glycosylated antigens. Glycobiology. 2002;12:443-50 pubmed
  196. Magner W, Kazim A, Stewart C, Romano M, Catalano G, Grande C, et al. Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J Immunol. 2000;165:7017-24 pubmed
  197. Knobeloch K, Wright M, Ochsenbein A, Liesenfeld O, Lohler J, Zinkernagel R, et al. Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions. Mol Cell Biol. 2000;20:5363-9 pubmed